Zydus Lifesciences Limited, an innovation-led global life sciences company, has announced the launch of PEPAIR™, India’s first affordable Oscillating Positive Expiratory Pressure (OPEP) device featuring a unique 3-resistance system. The drug-free, handheld respiratory device is designed to help patients suffering from chronic respiratory conditions such as COPD, asthma, and bronchiectasis by supporting effective mucus clearance and improving breathing.
The company has introduced PEPAIR™ at a patient-friendly price of Rs. 990 per unit, aiming to bridge the accessibility gap in airway clearance therapy across India. The device is being launched in partnership with AeroDel Technology Innovations Pvt. Ltd., a medical device company focused on inhalation drug delivery and pulmonary rehabilitation solutions.
What is PEPAIR™ and How Does It Work?
PEPAIR™ is an innovative OPEP device that creates positive pressure and oscillations during exhalation. These vibrations help loosen mucus trapped in the airways, open breathing passages, and promote better mucus clearance. The device is particularly beneficial for patients experiencing chronic mucus hypersecretion, a common complication in respiratory disorders.
OPEP therapy is clinically recommended for airway clearance. However, affordability constraints have historically limited access for a large section of patients. With PEPAIR™, Zydus aims to make daily respiratory care more accessible and practical for millions of Indians.
Addressing India’s Growing Respiratory Health Burden
More than 90 lakh patients in India suffer from chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), asthma, and bronchiectasis. Rising air pollution, climate-driven allergen changes, rapid urbanisation, and delayed diagnosis of lung diseases have significantly contributed to the surge in respiratory ailments across the country.
By offering a non-pharmacological, drug-free solution, PEPAIR™ provides an everyday airway clearance option that complements existing inhalation and oral therapies.